enVVeno Medical
NVNO
28 hedge funds and large institutions have $22.2M invested in enVVeno Medical in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 2 reducing their positions, and 3 closing their positions.
1,997% more call options, than puts
Call options by funds: $2.73M | Put options by funds: $130K
450% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 2
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
113% more capital invested
Capital invested by funds: $10.4M → $22.2M (+$11.7M)
27% more funds holding
Funds holding: 22 → 28 (+6)
0.34% more ownership
Funds ownership: 0.58% → 0.92% (+0.34%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.21M |
| 2 |
AC
Armistice Capital
New York
|
+$1.98M |
| 3 |
KCM
Kingdon Capital Management
New York
|
+$1.82M |
| 4 |
ACM
Altium Capital Management
New York
|
+$1.57M |
| 5 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$784K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$720K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$184K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$80.7K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$29K |
| 5 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
-$108 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $14.6K | +$12.7K | +80 | +8,000% |
|
27
Wells Fargo
San Francisco,
California
| $10.8K | +$159 | +1 | +2% |
|
28
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$318 | +2 | +200% |
|
29
Bank of America
Charlotte,
North Carolina
| $41 | – | – | – |
|
30
UBS Group
Zurich,
Switzerland
| $5 | – | – | – |
|
|
31
Simplex Trading
Chicago,
Illinois
| – | -$80.7K | -507 | Closed |
|
|
32
Group One Trading
Chicago,
Illinois
| – | -$29K | -182 | Closed |
|
|
NFSG
33
Newbridge Financial Services Group
Boca Raton,
Florida
| – | -$108 | -1 | Closed |
|
34
JP Morgan Chase
New York
| – | -$59 | – | – |
|
NVNO Hedge Fund Activity: Q4 2023 in Review
28 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q4 2023, worth a combined $22.2M — up 113% from $10.4M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NVNO positions and 3 closed out — a net gain of 6 holders — while 11 added to existing stakes and 2 trimmed.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $3.21M. The largest seller was Perceptive Advisors, cutting an estimated $720K.
- 28 institutional investors held enVVeno Medical (NVNO) as of Q4 2023, up from 22 in Q3 2023.
- Funds reported $22.2M of enVVeno Medical stock for Q4 2023, up 113% quarter-over-quarter.
- 9 funds opened new enVVeno Medical positions in Q4 2023 and 3 closed out, a net change of +6 holders.
- The largest enVVeno Medical buyer in Q4 2023 was Nantahala Capital Management, an estimated $3.21M added.
- The largest enVVeno Medical seller in Q4 2023 was Perceptive Advisors, an estimated $720K sold.
Based on aggregated 13F filings for Q4 2023.